Kemps-Polanco Reshema bought CRL
May 8, 2026 · Form 4 insider transaction
Kemps-Polanco Reshema bought 535 shares of Charles River Laboratories International, Inc. at $177.62 per share, a transaction worth $95.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
535
Price
$177.62
Total value
$95.0K
InsiderKemps-Polanco Reshema
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 8, 2026
Filing dateMay 11, 2026
Shares owned after4,563
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The grant was made in lieu of director service fees for the term commencing May 5, 2026. The restricted stock units vest upon the earlier of 5/8/2027, or the business day prior to the Company's next annual meeting of shareholders.